A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022

Tommy Nyberg(University of Cambridge), Anne M. Presanis(University of Cambridge), Joël Mossong(Luxembourg Institute of Health), Lamprini Veneti(Norwegian Institute of Public Health), Simon Thelwall(UK Health Security Agency), Josie Evans(Public Health Scotland), Peter Bager(Statens Serum Institut), Ajibola Omokanye(European Centre for Disease Prevention and Control), Tyra Grove Krause(Statens Serum Institut), Pedro Pinto Leite(Direção Geral do Território), Jostein Starrfelt(Norwegian Institute of Public Health), Heather M. Mutch(Public Health Scotland), Nick Bundle(European Centre for Disease Prevention and Control), Dritan Bejko(Luxembourg Institute of Health), André Peralta‐Santos(Direção Geral do Território), Robert J. Whittaker(University of Oxford), Richard Pebody(National Security Agency), Ingrid Bech Svalgaard(Statens Serum Institut), John Wood(Institute of High Energy Physics), Jim McMenamin(Public Health Scotland)
Eurosurveillance
September 7, 2023
Cited by 9


Related Papers